Lexology December 18, 2025
Holland & Knight LLP

Highlights

  • In 2025, there was heightened bipartisan scrutiny of healthcare consolidation at the state level, with a focus on the corporate practice of medicine and private equity investments.
  • At the same time, the Federal Trade Commission implemented significant changes to Hart-Scott-Rodino Act filing requirements and broadened its enforcement spotlight from only private equity groups to all stakeholders in the healthcare industry.
  • This Holland & Knight alert provides an overview of these actions and what they could mean for stakeholders moving into 2026.

As 2025 comes to a close, Holland & Knight antitrust and healthcare attorneys are analyzing how federal and state scrutiny of healthcare consolidation has reshaped the industry and providing intelligence on how to navigate 2026. The...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Congress / White House, Govt Agencies, Mergers & Acquisitions / JV, States, Trends
Related Articles:
Freeman Health System acquires Missouri facility to expand outpatient services
5 payer M&A deals | 2026
Healthcare & Life Sciences Private Equity Deal Tracker: Water Street Acquires Pillr From Renovus
Mirum Pharmaceuticals Completes $268.6 Million Acquisition of Bluejay Therapeutics to Strengthen Rare Disease Pipeline
Worldwide Clinical Trials to Buy Catalyst, Another M&A Deal Between Private Equity-Backed CROs

Share Article